http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 09 Mar 2026 16:05:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Bionano+to+Report+Fourth+Quarter+and+Full+Year+2025+Financial+Results+and+Host+a+Conference+Call+Webcast+on+March+23%2C+2026/26131935.html <p>SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:20%; width:20%; min-width:20%;;vertical-align: middle; text-align: left; padding-left: 10.0px; border-top: solid black http://www.streetinsider.com/Press+Releases/Bionano+to+Report+Fourth+Quarter+and+Full+Year+2025+Financial+Results+and+Host+a+Conference+Call+Webcast+on+March+23%2C+2026/26131935.html Mon, 09 Mar 2026 16:05:00 -0400 BNGO http://www.streetinsider.com/Globe+Newswire/Bionano+to+Report+Fourth+Quarter+and+Full+Year+2025+Financial+Results+and+Host+a+Conference+Call+Webcast+on+March+23%2C+2026/26131935.html <p>SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.</p> <p><strong>Conference Call &amp; Webcast Details</strong></p> <table style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:20%; width:20%; min-width:20%;;vertical-align: middle; text-align: left; padding-left: 10.0px; border-top: solid black http://www.streetinsider.com/Globe+Newswire/Bionano+to+Report+Fourth+Quarter+and+Full+Year+2025+Financial+Results+and+Host+a+Conference+Call+Webcast+on+March+23%2C+2026/26131935.html Mon, 09 Mar 2026 16:05:00 -0400 BNGO http://www.streetinsider.com/Press+Releases/Bionano+Symposium+2026+Concluded+with+9+Speakers+Describing+the+Breadth+of+Bionano+Solutions+and+Their+Potential+for+Use+on+a+Large+Scale/26075941.html <p>SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano’s Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that http://www.streetinsider.com/Press+Releases/Bionano+Symposium+2026+Concluded+with+9+Speakers+Describing+the+Breadth+of+Bionano+Solutions+and+Their+Potential+for+Use+on+a+Large+Scale/26075941.html Fri, 27 Feb 2026 08:00:00 -0400 BNGO http://www.streetinsider.com/Globe+Newswire/Bionano+Symposium+2026+Concluded+with+9+Speakers+Describing+the+Breadth+of+Bionano+Solutions+and+Their+Potential+for+Use+on+a+Large+Scale/26075941.html <p>SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automation, multiple OGM systems, and VIA™ software. Other talks covered topics like Bionano’s Ionic® system for isolating DNA and RNA for next generation sequencing (NGS) and advanced analytical tools that http://www.streetinsider.com/Globe+Newswire/Bionano+Symposium+2026+Concluded+with+9+Speakers+Describing+the+Breadth+of+Bionano+Solutions+and+Their+Potential+for+Use+on+a+Large+Scale/26075941.html Fri, 27 Feb 2026 08:00:00 -0400 BNGO http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Press+Releases/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html <p>SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled <em>OGM Making its Mark in Constitutional Genetic Disorders</em>. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to the cytogenetics and molecular pathology teams investigating them. Unlike hematologic malignancies, where established guidelines may better define the search for relevant chromosomal aberrations and genetic variants, the genetic drivers of constitutional disorders are more typically unknown, which makes Bionano’s end-to-end workflow http://www.streetinsider.com/Globe+Newswire/10+Presentations+on+Day+3+of+Bionano+Symposium+2026+Showcase+OGM%E2%80%99s+Utility+in+Unraveling+the+Complex+Puzzles+of+Constitutional+Genetic+Disorders/26064805.html Thu, 26 Feb 2026 08:00:00 -0400 A.04340865 A.04348055 A.38809575 A.50216700 BNGO O.02857491 O.07196654 O.11094194 O.20409495 O.50923497 http://www.streetinsider.com/Press+Releases/11+Presentations+on+Day+2+of+Bionano+Symposium+2026+Showcase+Expanding+Impact+of+Optical+Genome+Mapping+Across+Oncology+and+Cell+%26amp%3B+Gene+Therapy/26055472.html <p>SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and Bioprocessing Applications with Optical Genome Mapping (OGM). The session revealed how OGM can offer a new standard for detecting and characterizing structural variants (SVs) across cancer, including its unprecedented resolution in rare and heterogeneous cancers. Presentations also described how OGM is increasingly recognized, including by the US Food and Drug Administration (FDA), for its ability as a leading technique for highly sensitive analysis of genome integrity for http://www.streetinsider.com/Press+Releases/11+Presentations+on+Day+2+of+Bionano+Symposium+2026+Showcase+Expanding+Impact+of+Optical+Genome+Mapping+Across+Oncology+and+Cell+%26amp%3B+Gene+Therapy/26055472.html Wed, 25 Feb 2026 08:00:00 -0400 A.04348055 A.06822034 A.08435063 A.26221448 A.35954321 A.41168036 A.50214060 BNGO O.01671603 O.07196654 O.09607939 O.11094194 O.20026344 O.20032280 O.20737027 O.26149194